All Type of News


Inconvenient osteoporosis drugs to be changed to liquid and effervescent tabs

Osteoporosis, a disease weakening bone strength, is frequently found in post-menopausal middle-aged women. Those patients usually use bisphosphonate-type drugs, which are awfully inconvenient. Bisphosphonate-type dru...

Pfizer and Novartis increasing pharmaceutical distribution cost

Multinational pharmaceutical companies, such as Pfizer and Novartis which have expressed opposition to the pharmaceutical distribution cost raise, started to withdraw their prev...

GSK Korea President Jin-ho Kim will resigns

Jin-ho Kim, President of GSK Korea, will leave the leadership position. GSK announced President Jin-ho Kim, who has handled the North Asia region including Korea as a senior vi...

Patent expiration of ‘Baraclude’ different from Cialis

A large blockbuster market worth of KRW 150 billion sales will be opened. However, it was analyzed its generic market will be limited. It basically proves the importance of new drug development and the present conditi...

Feburic generics acquired additional sales approvals

Generic development of Feburic Tab(febuxostat), a gout treatment, has been fueled. The Ministry of Food and Drug Safety(MFDS) decided prohibition of its generic sales by the request of the patentee(the original compa...

Maximum 18% decrease on insurance claims by MERS

Damages caused by the MERS spread on medical institutions have been shown higher than the tentative estimation. The number of claims, which has been naturally increased, was also decreased by 17.6% at the maximum. Ac...

Hanmi-KPDA conflict came to an end

The confrontation of Hanmi Pharm and the Korea Pharmaceutical Distribution Association(KPDA), which has a conflict over the expansion of the pharmaceutical company into the phar...

Cialis generic war led by Cendom and Gugu on the early phase

On the early phase of the Cialis generic market, Chong Kun Dang’s ‘Cendom’ took the lead. Hanmi Pharm’s ‘Gugu’ outdistanced Cialis, the original, in prescription. In the market where 60 pharmaceutical companies jumpe...

Differentiated strategy of domestic pharmaceutical companies to catch Atozet

In the ezetimibe market represented by ‘Vytorin’ and ‘Atozet,’ domestic pharmaceutical companies have gotten ready to enter. The pharmaceutical companies have tried to attract interests of the market by differentiati...

Controversy over the breast cancer recommendation revision

It has been controversial as both opposing arguments were published in Korean Medical Association, stating “Must be revised” and “There is nothing wrong” about the revision for the breast cancer examination recommenda...

Most Read News


TOP
BACK
Address: 295-1, Chungpa-Ro, Yongsan-Gu, Korea
Phone: 02-3270-0114 | Fax: 02-3270-0129 | Email: eyd@yakup.com

Copyright © Yakup Shinmoon, Inc. All Rights Reserved.